Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2023, KP Rx is a founder-owned investment firm located in Sydney, Australia. The firm specializes in private and early-stage public healthcare investments, focusing on Australia and New Zealand. KP Rx aims to address the capital gap in healthcare commercialization in the region.
KP Rx invests in private and early-stage public healthcare companies, specifically those at or after Series A funding. The firm emphasizes biotech companies at Phase 2 and medical device companies that have received regulatory clearance. This targeted approach seeks to capitalize on the lack of dedicated capital for healthcare commercialization in Australia and New Zealand.
Notable portfolio companies include Kitea Health Ltd, Navi Medical Technologies Pty Ltd, Syntara Ltd, CurveBeam AI Ltd, Skin2Neuron Pty Ltd, and Inventia Life Science Pty Ltd.
Email your pitch deck to info@kp-rx.com for consideration.
Yes, KP Rx typically leads funding rounds for the companies it invests in, particularly at the Series A stage.
KP Rx is open to follow-on investments, especially for companies that demonstrate significant growth and potential in their respective sectors.
The specific size of KP Rx's current fund has not been disclosed, but the firm focuses on high-potential healthcare investments.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.